Alzheimers drug
Health
Second Alzheimer’s Drug to Slow Disease’s Progression
After Leqembi, another drug that might hit the market by the end of this year for Alzheimer's disease is Donanemab, and it's being developed by Eli Lilly. In a recent study, donanemab showed promise in slowing the progression of...
Diaspora
New Alzheimer’s Drug Developed By Greek Scientists
Aduhelm, a new, completely revolutionary treatment for the dreaded disease of Alzheimer's was approved on Wednesday by the FDA.